JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer

  • 0Department of Gastroenterology, Lanzhou University Second Hospital, Lanzhou, Gansu Province, China.
Current Medicinal Chemistry +

|

August 12, 2024

|

August 12, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Chemokines (CCL) show altered expression in gastric cancer, with some linked to pathological stage and survival. These findings suggest CCL chemokines could be potential immunotherapy targets and prognostic biomarkers for gastric cancer.

Area Of Science

  • Oncology
  • Immunology
  • Bioinformatics

Background

  • Gastric cancer is a prevalent gastrointestinal malignancy with significant health implications.
  • Chemokines of the CCL family are crucial in tumor microenvironments, yet their role in gastric cancer is under-explored.

Purpose Of The Study

  • To investigate the clinical significance and biological functions of CCL chemokines in gastric cancer.
  • To identify potential therapeutic targets and prognostic biomarkers for gastric cancer.

Main Methods

  • Utilized comprehensive bioinformatics analysis.
  • Employed databases and tools including cBioPortal, UALCAN, GEPIA, GeneMANIA, STRING, and TRRUST.
  • Analyzed mRNA expression levels, associations with pathological stage, and survival data.

Main Results

  • Observed differential mRNA expression of various CCL chemokines, with some upregulated and others downregulated.
  • Identified specific CCL chemokines (CCL2/11/19/21) significantly associated with gastric cancer pathological stage.
  • Found no association between CCL chemokine expression and disease-free survival, but low CCL14 expression correlated with longer overall survival.

Conclusions

  • CCL chemokines exhibit complex roles in gastric cancer.
  • These chemokines represent potential targets for gastric cancer immunotherapy.
  • CCL chemokines may serve as promising prognostic biomarkers for gastric cancer.

Keywords:

Related Concept Videos

Targeted Cancer Therapies 02:57

7.5K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists 01:28

156

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...

Mitogens and the Cell Cycle 02:38

6.4K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...